Teva and Microchips : Partnership through Digital Drug Delivery Technology. Opening of Teva R&D Center in Croatia - Israël Science Info
Winning the War on Huntington's Disease - WuXi XPress: for WuXi news and R&D insights
How One of the World's Leading Geneticists Recovered His Family's Stolen Legacy - Tablet Magazine
Former Teva Executives Raise $60 Million for Metabolic Disorders Venture | Ctech
Teva Pharmaceutical Industries Ltd. - At the opening of a new scientific research center in the Galilee region of Israel (pictured, left to right): Erez Vigodman, Teva President and CEO; Prof. Ran
Teva scraps Heptares migraine pact as lead drug nears clinic | Fierce Biotech
Incisive Genetics
Troubled Drugmaker Teva to Axe over 4,000 Jobs | Ctech
New Teva CEO axes R&D chief Hayden in boardroom shakeup -
Michael Hayden, MD, PhD - World Neuroscience Innovation Forum
New Teva CEO shakes up structure and executive ranks as major layoffs loom | Fierce Pharma
Israel Ministry of Foreign Affairs - Premier Kathleen Wynne visited Teva Pharmaceutical Industries Ltd., where she met with Dr. Michael Hayden, President of Global R&D and Chief Scientific Officer. Israeli Teva is
Podcast Transcript Michael Hayden and PROOF-HD v.1 08Jan2021
Teva appoints genetics specialist as its first president of global R&D - PMLiVE
New Teva CEO axes R&D chief Hayden in boardroom shakeup -
Prilenia Therapeutics raises $62.5m, names Michael Hayden CEO - Globes
Celebrating Biopharma Innovation: The Top 10 | Reuters Events | Pharma
Sitting down with… Dr Michael Hayden, Prilenia Therapeutics – Drug Discovery World (DDW)
Meet the Investigator – HD Insights
Michael Hayden, MD PhD | CMHF
Dr. Michael Hayden MBChB , PhD - Chief Executive Officer - Prilenia | LinkedIn
At Risk for Huntington's Disease: 'Darkness replaced by hope and light': taking stock of Huntington's disease research
Senior Advisors copy — Biolojic
Axovant poaches Allergan's and Teva's chief medical and science officers - PMLiVE
Chutes & Ladders—Teva rejigs C-suite amid major restructuring | Fierce Biotech
Michael HAYDEN | MBCHb PhD | University of British Columbia - Vancouver, Vancouver | UBC | Department of Medical Genetics
Oxford Biomedica Appoints Dr. Michael Hayden as
